InsiderTrades

Form 4 for VIR Vir Biotechnology, Inc.

Accepted 2021-12-16 00:00:00 ET · period of report 2021-12-14 · accession 0001209191-21-069994 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2021-12-16 2021-12-14+ VIR Virgin Herbert EVP, CSO, Research M - OptEx $1.53 +4,125 110.5K +4% +$6,311
DM 2021-12-16 2021-12-14+ VIR Virgin Herbert EVP, CSO, Research S - Sale+OE $48.63 -4,125 107.7K -4% -$200.6K
DM 2021-12-16 2021-12-14+ VIR Virgin Herbert EVP, CSO, Research M - OptEx $0.00 -4,125 226.4K -2% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-12-14 M A 1,375 $1.53 109,075 D — —
2 Common Common Stock 2021-12-15 S D 2,750 $50.00 107,700 D — —
3 Common Common Stock 2021-12-15 M A 2,750 $1.53 110,450 D — —
4 Common Common Stock 2021-12-14 S D 1,375 $45.88 107,700 D — —
5 Derivative Stock Option (Right to Buy) 2021-12-14 M D 1,375 $0.00 229,130 D $1.53 · — to 2028-01-26 1,375 Common Stock (F2) 1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter.
6 Derivative Stock Option (Right to Buy) 2021-12-15 M D 2,750 $0.00 226,380 D $1.53 · — to 2028-01-26 2,750 Common Stock (F2) 1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter.